BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/28/2020 10:08:51 AM | Browse: 1407 | Download: 2507
 |
Received |
|
2019-10-22 08:45 |
 |
Peer-Review Started |
|
2019-10-22 08:45 |
 |
First Decision by Editorial Office Director |
|
2019-12-05 22:00 |
 |
Return for Revision |
|
2019-12-11 09:46 |
 |
Revised |
|
2019-12-17 13:47 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2020-02-14 11:11 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2020-02-14 22:36 |
 |
Articles in Press |
|
2020-02-14 22:36 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2020-02-28 01:48 |
 |
Publish the Manuscript Online |
|
2020-02-28 10:08 |
| ISSN |
2308-3840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, Research & Experimental |
| Manuscript Type |
Systematic Reviews |
| Article Title |
L-carnitine supplementation in non-alcoholic fatty liver disease: A systematic review and meta-analysis
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Prarthana Thiagarajan, Jane Chalmers, Lu Ban, Douglas Grindlay and Guruprasad P Aithal |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Prarthana Thiagarajan, MBBS, MRCP, Academic Fellow, National Institute for Health Research Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and University of Nottingham, E Floor West Block Queens Medical Centre Derby Road, Nottingham NG7 2UH, United Kingdom. prarthana.thiagarajan@nottingham.ac.uk |
| Key Words |
L-Carnitine; Non-alcoholic fatty liver disease; Nonalcoholic steatohepatitis; Liver function; Insulin resistance; Meta-analysis |
| Core Tip |
Non-Alcoholic Fatty Liver Disease (NAFLD) presents a major public health challenge. As a leading cause of abnormal liver chemistry, rising in prevalence together with obesity and insulin resistance, there is critical unmet need to identify cost-effective, population-based treatment. We synthesised evidence from randomised trials published to date evaluating the effect of dietary L-carnitine supplementation on transaminases, liver fat and insulin resistance in NAFLD. We demonstrate a significant reduction in serum alanine aminotransferase, homeostasis model of insulin resistance and liver fat with dietary L-carnitine supplementation. L-carnitine could therefore present a novel therapeutic tool for NAFLD and its metabolic associations. |
| Publish Date |
2020-02-28 10:08 |
| Citation |
Thiagarajan P, Chalmers J, Ban L, Grindlay D, Aithal GP. L-carnitine supplementation in non-alcoholic fatty liver disease: A systematic review and meta-analysis. World J Meta-Anal 2020; 8(1): 4-14 |
| URL |
https://www.wjgnet.com/2308-3840/full/v8/i1/4.htm |
| DOI |
https://dx.doi.org/10.13105/wjma.v8.i1.4 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.